ReviewJournal of migration and health2026
A scoping review of the available literature on the epidemiologic profile of migrants in-transit through South America, Central America, and Mexico from 2013-2025.
Review in Journal of migration and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migration through Latin America has increased, resulting in new routes and greater diversity among migrants. Timely, accurate data on the epidemiologic profiles of migrants in-transit could inform public health surveillance and interventions. Objective: Provide an overview of the type of data collected on the epidemiologic profiles of migrants in-transit through South America, Central America, and Mexico. Methods: We conducted a scoping review from peer-reviewed and grey literature reporting quantitative health data on selected infectious and non-infectious diseases, vaccination coverage, and causes of mortality migrants in-transit through South America, Central America, and Mexico between 2013 and 2025 by searching Embase, Medline, Global Health, Sociological Abstracts, Scopus, LILACS, NTIS, OpenGrey, and MedRxlv. Results: We identified 7,355 publications; 124 met inclusion criteria. Of these, 24% specified a transit migration phase. Cross-sectional methodology was employed in 86%; and 62% were published in the last four years (2022-2025). Sociodemographic variables were inconsistently reported, and migration-related variables were infrequent. Health concepts frequently investigated included HIV (28%), TB (14%) COVID-19 (15%), mental health (33%), food insecurity (14%), mortality (10%) and vaccination (6%). Chronic conditions were frequently reported as comorbidities. Conclusion: Limited detailed information is available to inform health surveillance and interventions among migrants in-transit. Additional migration-related variables, including time in-transit and transit migration phase, an expansion of data collection to geographical areas experiencing an increase in mobility, and rigorous study designs could yield valuable insights.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.